Yuyu Pharma, Inc. (000220.KS)
000220.KS Stock Price Chart
Explore Yuyu Pharma, Inc. interactive price chart. Choose custom timeframes to analyze 000220.KS price movements and trends.
000220.KS Company Profile
Discover essential business fundamentals and corporate details for Yuyu Pharma, Inc. (000220.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
253.00
Website
https://www.yuyu.co.krCEO
Wonsang Yu
Description
Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.
000220.KS Financial Timeline
Browse a chronological timeline of Yuyu Pharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2024
EPS came in at -₩45.43 , while revenue for the quarter reached ₩32.97B .
Dividend declared on 27 Dec 2024
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 1 Apr 2025.
Earnings released on 30 Sept 2024
EPS came in at ₩187.70 , while revenue for the quarter reached ₩33.60B .
Earnings released on 29 Jun 2024
EPS came in at ₩76.72 , while revenue for the quarter reached ₩33.18B .
Earnings released on 30 Mar 2024
EPS came in at ₩319.88 , while revenue for the quarter reached ₩33.40B .
Earnings released on 30 Dec 2023
EPS came in at -₩67.14 , while revenue for the quarter reached ₩34.61B .
Earnings released on 30 Sept 2023
EPS came in at -₩167.60 , while revenue for the quarter reached ₩34.09B .
Earnings released on 30 Jun 2023
EPS came in at -₩213.76 , while revenue for the quarter reached ₩34.22B .
Earnings released on 31 Mar 2023
EPS came in at ₩28.02 , while revenue for the quarter reached ₩34.29B .
Earnings released on 31 Dec 2022
EPS came in at -₩109.75 , while revenue for the quarter reached ₩34.74B .
Dividend declared on 28 Dec 2022
A dividend of ₩105.00 per share was announced, adjusted to ₩105.00. The dividend was paid on 14 Apr 2023.
Earnings released on 30 Sept 2022
EPS came in at -₩99.46 , while revenue for the quarter reached ₩34.14B .
Earnings released on 30 Jun 2022
EPS came in at -₩53.43 , while revenue for the quarter reached ₩34.47B .
Earnings released on 31 Mar 2022
EPS came in at -₩4.38 , while revenue for the quarter reached ₩35.53B .
Earnings released on 31 Dec 2021
EPS came in at -₩109.48 , while revenue for the quarter reached ₩31.15B .
Dividend declared on 29 Dec 2021
A dividend of ₩105.00 per share was announced, adjusted to ₩105.00. The dividend was paid on 20 Apr 2022.
Earnings released on 30 Sept 2021
EPS came in at -₩41.00 , while revenue for the quarter reached ₩29.78B .
Earnings released on 30 Jun 2021
EPS came in at -₩14.00 , while revenue for the quarter reached ₩28.23B .
Earnings released on 31 Mar 2021
EPS came in at ₩27.00 , while revenue for the quarter reached ₩26.50B .
Stock split effective on 30 Mar 2021
Shares were split 2 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 23 Feb 2021
EPS came in at -₩42.92 , while revenue for the quarter reached ₩24.67B .
Dividend declared on 29 Dec 2020
A dividend of ₩210.00 per share was announced, adjusted to ₩105.00. The dividend was paid on 19 Apr 2021.
Earnings released on 16 Nov 2020
EPS came in at ₩53.00 , while revenue for the quarter reached ₩25.50B .
000220.KS Stock Performance
Access detailed 000220.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.